Analgesics (Pharmacies) - Laos

  • Laos
  • Revenue in the Analgesics market is projected to reach US$1.44m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 8.75%, resulting in a market volume of US$2.19m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.19 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Laos is experiencing steady growth due to increasing customer preferences for over-the-counter pain relief medications.

Customer preferences:
Laotian consumers are increasingly seeking convenient and affordable solutions for managing pain. As a result, there is a growing preference for analgesics that can be purchased without a prescription from pharmacies. This trend is driven by the desire for quick and easy access to pain relief, as well as the rising awareness of the effectiveness and safety of over-the-counter medications. Additionally, the affordability of analgesics compared to prescription drugs makes them a more attractive option for many consumers.

Trends in the market:
One of the key trends in the Analgesics market in Laos is the growing demand for non-steroidal anti-inflammatory drugs (NSAIDs). These medications are commonly used to relieve pain, reduce inflammation, and lower fever. The increasing prevalence of conditions such as arthritis and musculoskeletal disorders in the country has contributed to the rising demand for NSAIDs. Additionally, the availability of a wide range of brands and formulations in pharmacies has further fueled the growth of this segment. Another trend in the market is the rising popularity of topical analgesics. These products, such as creams, gels, and patches, are applied directly to the skin to provide localized pain relief. The convenience and ease of use offered by topical analgesics have made them a preferred choice for consumers seeking targeted pain relief. Moreover, the availability of a variety of formulations, including those containing natural ingredients, has also contributed to their growing popularity.

Local special circumstances:
Laos is a developing country with a growing healthcare sector. The government has been making efforts to improve access to healthcare services, including the availability of essential medications. As a result, there has been an increase in the number of pharmacies across the country, providing easier access to analgesics for the population. Additionally, the rising disposable incomes and changing lifestyles of Laotian consumers have also contributed to the growth of the Analgesics market.

Underlying macroeconomic factors:
The steady economic growth in Laos has played a significant role in the development of the Analgesics market. The country has experienced a rise in per capita income, leading to an increase in healthcare expenditure. This has allowed consumers to allocate a larger portion of their budget towards purchasing analgesics. Furthermore, the expanding middle class in Laos has also contributed to the growth of the market, as these consumers have a higher purchasing power and are more likely to seek healthcare products. In conclusion, the Analgesics (Pharmacies) market in Laos is witnessing growth due to increasing customer preferences for over-the-counter pain relief medications. The demand for NSAIDs and topical analgesics is on the rise, driven by the need for convenient and affordable solutions for managing pain. The growing number of pharmacies and improving healthcare infrastructure in Laos, coupled with the country's steady economic growth, are key factors contributing to the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)